Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
Ellen C. de Heer, Mathilde Jalving, Adrian L. Harris
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5074-5087
Open Access | Times Cited: 265
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 187
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 172
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2252-2252
Open Access | Times Cited: 154
Metabolic pathways in obesity-related breast cancer
Kristy A. Brown
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 6, pp. 350-363
Open Access | Times Cited: 139
Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer
Yi-Feng Hou, Shuang Cai, Shouyang Yu, et al.
Acta Biochimica et Biophysica Sinica (2021) Vol. 53, Iss. 3, pp. 333-341
Open Access | Times Cited: 83
Insulin Resistance and Cancer: In Search for a Causal Link
Eusebio Chiefari, Maria Mirabelli, Sandro La Vignera, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11137-11137
Open Access | Times Cited: 82
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
Samson Mathews Samuel, Elizabeth Varghese, Dietrich Büsselberg
Trends in Microbiology (2021) Vol. 29, Iss. 10, pp. 894-907
Open Access | Times Cited: 81
Metformin and Breast Cancer: Where Are We Now?
Mónica Cejuela Solís, Begoña Martı́n-Castillo, Javier A. Menéndez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2705-2705
Open Access | Times Cited: 63
Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway
Lin Cheng, Xu Zhang, Yuzhou Huang, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 62
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 6, pp. e1009634-e1009634
Open Access | Times Cited: 60
Metformin and Breast Cancer: Current Findings and Future Perspectives from Preclinical and Clinical Studies
Karen A. Corleto, Jenna L. Strandmo, Erin D. Giles
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 396-396
Open Access | Times Cited: 10
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
Ziyi Chen, Yi Zhao
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Nutritional Value and Preventive Role of Nigella sativa L. and Its Main Component Thymoquinone in Cancer: An Evidenced-Based Review of Preclinical and Clinical Studies
Johura Ansary, Francesca Giampieri, Tamara Y. Forbes‐Hernández, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2108-2108
Open Access | Times Cited: 42
Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil
Jung Ho Han, Min-Jeong Kim, Hyeon Jin Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5406-5406
Open Access | Times Cited: 40
Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century
Marta Sumińska, Rafał Podgórski, Klaudia Bogusz‐Górna, et al.
Obesity Reviews (2022) Vol. 23, Iss. 6
Closed Access | Times Cited: 27
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 17
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3665-3682
Open Access | Times Cited: 16
Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study
Ondřej Fiala, Sebastiano Buti, Kazutoshi Fujita, et al.
Clinical & Experimental Metastasis (2025) Vol. 42, Iss. 2
Open Access
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Chris R. Triggle, Hong Ding, Isra Marei, et al.
Canadian Journal of Physiology and Pharmacology (2020) Vol. 98, Iss. 7, pp. 415-430
Closed Access | Times Cited: 43
Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
Wenhui Liu, Ying Wang, Jian‐Quan Luo, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 32
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2482-2482
Open Access | Times Cited: 38
Implications of flavonoids as potential modulators of cancer neovascularity
Alena Líšková, Lenka Koklesová, Marek Samec, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 12, pp. 3079-3096
Closed Access | Times Cited: 38
Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC
Mousa Sha’at, A Spac, Iulian Stoleriu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1187-1187
Open Access | Times Cited: 21
Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer
Syn Kok Yeo, Ritama Paul, Michael Haas, et al.
Autophagy (2018) Vol. 14, Iss. 7, pp. 1214-1225
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top